Humacyte, Inc
Humacyte is a pioneering regenerative medicine company dedicated to developing bioengineered human tissues and organs that are designed to be universally implantable, off-the-shelf, and regenerative. Their mission is to improve patient outcomes by transforming human cells into regenerative tissues for treating a wide range of diseases, injuries, and chronic conditions. They focus on innovative platforms including Acellular Tissue Engineered Vessels, Advanced Organ Systems, and Advanced Tissue Constructs, with a goal of making tissue repair and replacement accessible to a broader patient population.
Industries
Nr. of Employees
medium (51-250)
Humacyte, Inc
Products
Acellular tissue‑engineered vascular graft (commercial biologic vessel for vascular repair)
A human-derived, decellularized tissue-engineered vascular conduit produced from expanded human vascular cells on biodegradable polymer scaffolds, intended as an off-the-shelf regenerative implant for vascular repair and bypass procedures.
Investigational bioengineered organ and tissue constructs
Preclinical-stage constructs and organ system adaptations of the vascular tissue platform, including vascularized pancreas constructs for Type 1 diabetes, lung constructs, urinary conduits, tracheal and esophageal replacements.
Acellular tissue‑engineered vascular graft (commercial biologic vessel for vascular repair)
A human-derived, decellularized tissue-engineered vascular conduit produced from expanded human vascular cells on biodegradable polymer scaffolds, intended as an off-the-shelf regenerative implant for vascular repair and bypass procedures.
Investigational bioengineered organ and tissue constructs
Preclinical-stage constructs and organ system adaptations of the vascular tissue platform, including vascularized pancreas constructs for Type 1 diabetes, lung constructs, urinary conduits, tracheal and esophageal replacements.
Services
Medical information and clinical support
Provision of product-related medical information, clinical education, and peer-to-peer discussion resources for healthcare professionals and investigators.
Coding and reimbursement support
Assistance for healthcare providers seeking coding and reimbursement information related to product use.
Expanded access and humanitarian program implementation
Operational support and clinician training to deploy investigational tissue-engineered vascular products under expanded access programs.
Medical information and clinical support
Provision of product-related medical information, clinical education, and peer-to-peer discussion resources for healthcare professionals and investigators.
Coding and reimbursement support
Assistance for healthcare providers seeking coding and reimbursement information related to product use.
Expanded access and humanitarian program implementation
Operational support and clinician training to deploy investigational tissue-engineered vascular products under expanded access programs.
Expertise Areas
- Regenerative medicine and tissue engineering
- Biomanufacturing scale-up for implantable biologics
- Decellularization and extracellular matrix engineering
- Preclinical translational modeling and large-animal studies
Key Technologies
- Acellular tissue-engineered vascular grafts
- Decellularization preserving ECM proteins
- Bioreactor systems with biomechanical conditioning
- Biodegradable polymer mesh scaffolds